Vivos Therapeutics, Inc. (VVOS) at a glance

Vivos Therapeutics, Inc. (VVOS) is a micro-cap Healthcare company. It trades at $0.45, with a -127.7% profit margin and revenue growth of 70.5%. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Momentum (13/100). It carries above-market volatility, so expect larger swings.

Price

$0.45

Market cap

$7.9M

P/E ratio

n/a

Dividend yield

None

Beta

6.08

52-week range

$0.38 to $7.95